No definition available.
Other congenital malformations of circulatory system
EFO MESH Endpoint Browser PheWeb
Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
911 |
4. Check minimum number of eventsNone |
911 |
5. Include endpointsNone |
911 |
6. Filter based on genotype QC (FinnGen only) |
911 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_CIRCULATO_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q2
- Name in latin
- Aliae malformationes congenitae systematis circulatorii
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of circulatory system
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of the circulatory system
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5679 | 2954 | 2695 |
| Only index persons | 5251 | 2773 | 2478 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.08 | 0.08 |
| Only index persons | 0.10 | 0.10 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 50.81 | 51.53 | 50.08 |
| Only index persons | 51.08 | 51.74 | 50.35 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 911 | 525 | 386 |
| Unadjusted period prevalence (%) | 0.18 | 0.18 | 0.17 |
| Median age at first event (years) | 53.93 | 51.63 | 57.06 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 817
- Matched controls
- 8169
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
+∞
323.0
443
*
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
+∞
323.0
339
*
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
52.2
106.9
128
29
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
8.7
94.7
226
345
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
54.6
88.5
105
22
AAC40
NOMESCO Finland
Extirpation of intracranial arterio-venous malformation
+∞
76.3
72
*
AA1AD
NOMESCO Finland
CT of head and brain
4.4
73.2
338
1120
Q28.8
ICD-10 Finland
Other specified congenital malformations of circulatory system
+∞
67.7
64
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
27.9
66.8
92
37
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
12.6
61.5
114
104
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
8.4
60.0
141
199
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
16.4
52.5
86
58
PA2JT
NOMESCO Finland
Very extensive embolisation of arterio-venous malformation of the brain
+∞
48.4
46
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.9
47.8
232
752
PA2HT
NOMESCO Finland
Extensive embolisation of arterio-venous malformation of the brain
+∞
44.2
42
*
N03AF02
ATC
oxcarbazepine; oral
9.4
44.0
94
111
Q28.0
ICD-10 Finland
Arteriovenous malformation of precerebral vessels
+∞
41.0
39
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.8
40.8
148
358
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
59.4
38.7
45
8
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
13.4
38.4
68
55
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
27.1
37.2
51
20
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.5
35.3
67
63
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
81.9
35.1
39
5
G40.9
ICD-10 Finland
Epilepsy, unspecified
8.0
34.6
81
111
XA800
NOMESCO Finland
Neuropsychological investigation
6.5
34.2
93
158
PA2GT
NOMESCO Finland
Embolisation of arterio-venous malformation of the brain
+∞
33.6
32
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
11.9
32.8
61
55
N03AF01
ATC
carbamazepine; oral, rectal
5.8
31.8
95
182
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
10.4
31.7
63
65
H93.1
ICD-10 Finland
Tinnitus
4.8
31.5
112
262
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
16.1
30.8
50
33
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
53.7
30.6
36
7
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
30.3
291
1439
D18.0
ICD-10 Finland
Haemangioma, any site
9.5
30.2
63
71
R51.80
ICD-10 Finland
Headache
3.2
29.6
181
674
Q28.1
ICD-10 Finland
Other malformations of precerebral vessels
+∞
29.3
28
*
N03AX14
ATC
levetiracetam; systemic
8.0
28.1
65
87
Q28.9
ICD-10 Finland
Congenital malformation of circulatory system, unspecified
+∞
27.2
26
*
XCK00
NOMESCO Finland
Perimetry
4.7
27.2
98
231
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.6
23.2
83
194
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
14.7
22.8
38
27
H53.4
ICD-10 Finland
Visual field defects
9.7
22.1
45
49
I77.0
ICD-10 Finland
Arteriovenous fistula, acquired
118.2
21.7
23
*
G40.10
ICD-10 Finland
Simple partial seizures
18.5
21.0
32
18
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.9
20.9
48
64
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
78.9
20.8
23
*
R4110
NOMESCO Finland
Physiotherapy
2.3
20.6
251
1345
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
17.5
20.6
32
19
XX4AW
NOMESCO Finland
NA
27.9
20.1
27
10
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
25.7
18.3
25
10
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
17.7
147
644
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.2
16.2
91
312
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
30.7
16.2
21
7
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
48.5
16.1
19
*
AAC30
NOMESCO Finland
Intracranial occlusion of vascular fistula
+∞
15.7
15
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
9.4
15.3
31
34
N03AX18
ATC
lacosamide; systemic
18.2
15.2
23
13
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
25.6
14.7
20
8
H53.2
ICD-10 Finland
Diplopia
4.8
14.5
48
104
WX002
NOMESCO Finland
Sedation and analgesia
2.1
14.4
179
950
N03AB02
ATC
phenytoin; systemic
10.3
14.0
27
27
PA5AC
NOMESCO Finland
Angiography of arteries to the face with X-ray
+∞
13.6
13
*
ZXC95
NOMESCO Finland
Use of surgical navigator
9.0
13.6
28
32
R20.2
ICD-10 Finland
Paraesthesia of skin
3.0
13.2
77
272
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
11.2
12.6
23
21
183
Kela drug reimbursment
Lamotrigin and topiramate
9.5
12.5
25
27
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
12.5
140
705
G44.2
ICD-10 Finland
Tension-type headache
2.2
12.3
131
645
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
38.2
12.2
15
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
12.2
143
735
N03AG01
ATC
valproic acid; systemic, rectal
3.0
12.2
70
244
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
11.3
12.1
22
20
R4150
NOMESCO Finland
Neuropsychological rehabilitation
10.3
12.0
23
23
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.8
12.0
81
312
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.2
11.9
62
202
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
47.4
11.9
14
*
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
11.3
11.6
21
19
Q27.3
ICD-10 Finland
Peripheral arteriovenous malformation
+∞
11.5
11
*
R4120
NOMESCO Finland
Occupational therapy
2.9
11.5
70
254
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
8.5
11.4
24
29
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
25.4
11.2
15
6
K90
ICPC
Stroke/cerebrovascular accident
5.7
11.1
31
56
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
8.7
11.1
23
27
XX4BW
NOMESCO Finland
NA
28.4
10.7
14
5
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.4
10.7
97
442
N18
ICPC
Paralysis/weakness
6.7
10.6
26
40
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
10.2
10.5
20
20
PA5JT
NOMESCO Finland
Embolisation of very extensive arterio-venous malformation of carotis externa area
+∞
10.4
10
*
AA9CW
NOMESCO Finland
NA
19.1
10.3
15
8
N02BE01
ATC
paracetamol; systemic, rectal
1.8
10.2
686
6040
K91
ICPC
Cerebrovascular disease
8.0
10.2
22
28
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
10.0
113
567
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
6.6
9.8
24
37
WX882
NOMESCO Finland
High dependency care
4.3
9.8
35
84
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.3
9.5
47
149
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
17.8
9.4
14
8
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
30.4
9.4
12
*
G40
ICD-10 Finland
Epilepsy
8.2
9.4
20
25
R51
ICD-10 Finland
Headache
2.9
9.3
56
203
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9.7
9.3
18
19
H53.1
ICD-10 Finland
Subjective visual disturbances
2.7
9.2
63
248
WX892
NOMESCO Finland
Monitored bed care
2.5
9.1
69
287
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.2
9.1
47
154
WX110
NOMESCO Finland
Local anesthesy
1.6
8.9
544
4541
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
24.3
8.9
12
5
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
8.9
173
1066
N03AX09
ATC
lamotrigine; oral
2.9
8.6
50
178
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.8
8.5
35
96
ZX050
NOMESCO Finland
Stereotactic radiotherapy
7.5
8.5
19
26
Q82.2
ICD-10 Finland
Mastocytosis
91.0
8.4
9
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
8.3
8
*
N03AX16
ATC
pregabalin; oral
1.7
8.3
185
1189
G40.89
ICD-10 Finland
Other epilepsy
14.7
8.2
13
9
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
8.2
322
2399
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.4
8.2
68
297
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.5
8.0
59
242
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
22.3
8.0
11
5
AA5PD
NOMESCO Finland
CT examination of brain pefusion
7.9
7.9
17
22
R42
ICD-10 Finland
Dizziness and giddiness
1.8
7.9
159
990
AAF00
NOMESCO Finland
Ventriculostomy
8.6
7.8
16
19
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
10.9
7.8
14
13
TAB00
NOMESCO Finland
Lumbar puncture
2.8
7.8
49
183
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
15.2
7.7
12
8
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
2.9
7.7
45
161
M79.6
ICD-10 Finland
Pain in limb
1.6
7.7
273
1978
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
7.6
180
1174
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.2
7.6
75
358
M03BX01
ATC
baclofen; systemic
4.9
7.5
23
48
PG1GT
NOMESCO Finland
Endovascular embolisation of arterio-venous malformation with radiological guidance not elsewhere classified
+∞
7.3
7
*
7478X
ICD-9 Finland
Other congenital anomalies of circulatory system, Other specified anomalies of circulatory system
+∞
7.3
7
*
4301A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACH.POST MALFORMAT.ARTERIOVENOSAM]
+∞
7.3
7
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.9
7.2
105
587
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
7.2
157
997
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
20.2
7.1
10
5
L28
ICPC
Limited function/disability (L)
1.9
7.0
108
614
ZXA00
NOMESCO Finland
Right side
1.6
7.0
198
1354
Z71.8
ICD-10 Finland
Other specified counselling
1.6
6.8
176
1172
PA2CG
NOMESCO Finland
Extensive MRI examination of vessels in the head with high intensity magnet
11.1
6.8
12
11
N03AX12
ATC
gabapentin; oral
1.8
6.8
120
713
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
40.4
6.8
8
*
DFF00
NOMESCO Finland
Pure tone audiometry
2.2
6.7
69
336
RS222
NOMESCO Finland
NA
6.5
6.7
16
25
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.5
6.6
48
197
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
12.4
6.6
11
9
I63.8
ICD-10 Finland
Other cerebral infarction
8.8
6.6
13
15
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
7.5
6.4
14
19
TKC20
NOMESCO Finland
Catheterisation of bladder
2.4
6.4
52
227
PA2AD
NOMESCO Finland
CT angiography of brain
8.2
6.3
13
16
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
5.6
6.3
17
31
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
6.3
59
276
N05BA01
ATC
diazepam; systemic, rectal
1.8
6.3
104
604
R51.81
ICD-10 Finland
Facial pain NOS
4.4
6.3
21
49
PC6CC
NOMESCO Finland
Spinal angiography, very extensive
+∞
6.3
6
*
Q27.9
ICD-10 Finland
Congenital malformation of peripheral vascular system, unspecified
+∞
6.3
6
*
Q27.4
ICD-10 Finland
Congenital phlebectasia
+∞
6.3
6
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.6
6.2
26
74
I78.0
ICD-10 Finland
Hereditary haemorrhagic telangiectasia
26.9
6.2
8
*
R47.0
ICD-10 Finland
Dysphasia and aphasia
6.3
6.2
15
24
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
7.8
6.1
13
17
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
5.0
6.1
18
37
N05BA09
ATC
clobazam; oral
8.7
6.1
12
14
N28
ICPC
Limited function/disability (N)
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
103
52
22.21
136.07
1.8
1.8
—
—
—
0
0
157
373
4.88
62.74
8.7
11.0
24.4
24.4
mmol/l
0.06
151
352
218
787
3.33
47.50
8.5
8.9
0.9
1.2
mmol/l
0.42
162
634
216
785
3.30
46.46
8.5
8.9
5.1
5.1
kpa
0.36
209
758
216
785
3.30
46.46
8.5
8.9
17.3
12.6
kpa
12.38
209
760
411
2168
2.63
43.76
2.3
2.1
145.0
221.9
u/l
1.56
398
2047
42
39
11.24
39.33
2.5
2.4
49.1
50.8
umol/l
0.11
37
31
623
4327
2.39
32.39
6.8
5.0
6.4
6.7
mmol/l
2.88
595
4044
329
1790
2.31
30.19
2.4
2.3
—
—
—
0
0
32
30
11.02
29.69
3.0
3.1
28.4
34.6
umol/l
1.10
24
22
503
3271
2.20
29.54
7.7
6.5
1.2
1.2
mmol/l
2.46
472
2975
526
3593
2.10
25.84
7.9
7.1
1.2
1.2
mmol/l
1.45
464
3058
500
3519
1.93
20.72
3.9
4.0
—
—
—
0
0
132
619
2.32
16.15
10.7
8.4
1.4
1.3
mmol/l
0.06
122
594
310
2005
1.83
15.50
4.1
3.1
0.4
0.5
e6/l
0.30
240
1498
206
1189
1.95
14.55
4.0
3.6
0.8
0.8
mmol/l
0.29
190
1122
237
1490
1.80
12.59
3.2
2.5
5.2
6.0
e6/l
0.46
206
1311
159
886
1.96
12.28
10.0
7.6
105.4
104.1
mmol/l
2.77
159
866
205
1242
1.84
12.26
3.2
2.8
1.4
1.1
e6/l
0.77
124
713
52
179
3.02
11.79
2.6
1.3
18.8
10.5
e6/l
0.24
38
139
52
179
3.02
11.79
2.6
1.4
467.1
754.9
e6/l
0.17
42
143
842
7642
2.34
10.90
18.6
13.4
24.1
23.0
mg/l
0.42
717
5952
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
54
205
2.74
10.27
3.9
2.9
0.4
0.4
u/ml
0.11
30
110
362
2711
1.56
9.22
3.4
3.4
29.3
36.5
ng/l
0.35
258
1816
850
7827
2.28
9.21
21.8
15.1
139.5
139.7
mmol/l
0.95
837
7626
123
695
1.89
9.00
2.2
2.4
32.3
41.6
u/l
0.68
106
595
184
1174
1.71
8.96
3.5
2.9
2.4
2.5
e6/l
0.04
102
653
850
7849
2.24
8.77
21.6
15.2
3.9
4.0
mmol/l
2.14
836
7638
111
623
1.89
8.28
6.8
8.2
7.5
8.9
mmol/l
1.28
106
591
482
3898
1.50
8.27
6.8
6.5
11.1
11.7
umol/l
0.50
457
3695
154
955
1.74
8.27
5.3
6.0
1.0
1.0
mmol/l
0.05
140
889
34
113
3.09
8.23
1.4
1.2
4.0
5.2
u/ml
0.18
16
45
14
23
6.17
8.20
1.1
1.7
74.8
91.3
%
—
6
14
14
24
5.91
7.87
1.1
1.0
75.8
91.9
%
—
6
15
195
1310
1.62
7.70
3.3
3.6
951.4
345.0
ng/l
0.65
149
978
393
3082
1.48
7.65
5.0
5.0
35.2
35.9
g/l
1.35
371
2879
33
115
2.94
7.39
1.0
1.1
—
—
—
0
0
70
353
2.06
7.09
7.3
4.8
23.7
24.2
mmol/l
0.65
64
317
138
890
1.65
6.34
3.6
2.9
7.9
7.4
umol/l
0.12
118
775
20
59
3.44
5.89
1.2
1.1
231.3
228.4
mg/l
0.04
20
54
651
5777
1.44
5.78
7.8
7.6
77.1
77.6
u/l
0.14
622
5423
30
114
2.69
5.78
1.4
1.2
4.7
2.4
u/ml
—
9
36
232
1715
1.47
5.77
2.4
1.8
1.4
1.2
mg/l
0.39
190
1291
25
86
2.96
5.76
1.0
1.1
—
—
—
0
0
22
72
3.11
5.52
1.0
1.1
—
—
—
0
0
783
7237
1.58
5.46
16.6
12.0
85.3
83.7
ml/min/173m2
1.24
690
5924
102
634
1.69
5.39
6.4
4.5
1.2
2.0
mmol/l
0.93
90
502
115
738
1.64
5.38
2.2
2.0
380.6
364.6
nmol/l
0.39
108
688
130
865
1.59
5.24
14.4
20.5
1.1
1.2
inr
0.32
12
125
591
5203
1.39
5.14
3.5
3.1
47.8
47.1
u/l
0.07
559
4883
31
129
2.45
5.01
3.9
5.2
371.9
373.4
umol/l
0.02
26
117
23
83
2.82
4.90
1.0
1.1
—
—
—
0
0
860
8189
1.90
4.82
11.7
10.2
27.7
26.5
u/l
0.32
827
7924
72
419
1.78
4.82
1.6
1.7
—
—
—
0
0
628
5616
1.38
4.75
4.1
4.1
10.1
11.3
mm/h
1.68
595
5196
95
600
1.65
4.74
1.8
2.4
4.6
7.5
ug/l
1.68
82
543
31
134
2.36
4.64
1.9
1.3
—
—
—
0
0
31
134
2.36
4.64
1.9
1.3
—
—
—
0
0
508
4412
1.34
4.55
10.8
9.3
3.9
4.1
e9/l
0.74
430
3873
71
422
1.74
4.43
1.4
1.5
—
—
—
0
0
352
2908
1.34
4.36
2.0
1.9
94.2
96.0
pmol/l
0.32
185
1530
755
7011
1.45
4.26
5.1
4.6
1.8
2.1
mu/l
0.75
710
6436
17
57
3.02
4.14
1.0
1.1
—
—
—
0
0
310
2529
1.34
4.13
3.7
3.4
34.5
31.5
u/l
0.38
299
2411
135
959
1.48
4.03
2.4
2.4
25.7
22.9
%
1.01
120
824
143
1030
1.46
3.97
2.3
2.4
2.2
2.3
g/l
1.25
133
960
298
2450
1.32
3.69
3.5
3.4
2.4
2.4
mmol/l
0.08
260
2169
9
16
5.67
3.66
1.4
1.7
18.2
17.9
umol/l
—
9
16
12
35
3.46
3.62
1.1
1.1
—
—
—
0
0
107
744
1.50
3.55
3.8
3.2
—
—
—
0
0
10
26
3.88
3.53
1.0
1.2
—
—
—
0
0
14
47
3.01
3.42
1.0
1.1
—
—
—
0
0
12
37
3.27
3.35
1.3
4.5
156.2
112.3
umol/l
—
5
21
385
3317
1.28
3.26
2.9
2.8
127.1
119.9
ug/l
0.23
362
3083
148
1113
1.39
3.24
2.3
2.4
14.0
13.3
umol/l
0.44
138
1031
76
502
1.56
3.21
1.6
1.6
—
—
—
0
0
697
6477
1.32
3.19
23.5
16.2
13.7
13.6
%
0.21
689
6348
169
1302
1.37
3.19
2.9
2.9
2.4
2.4
mmol/l
0.67
141
1155
13
44
2.98
3.14
2.9
1.5
—
—
—
0
0
6
8
7.54
3.06
1.2
1.0
—
—
—
0
0
637
5867
1.29
3.00
4.3
3.9
14.7
14.7
pmol/l
0.21
596
5353
151
1154
1.37
3.00
1.9
1.9
—
—
—
0
0
13
46
2.85
2.92
1.0
1.0
1.0
1.1
u/l
—
6
25
56
353
1.62
2.89
1.9
1.3
30.3
26.9
iu/l
0.28
49
301
7
13
5.42
2.87
1.0
1.1
—
—
—
0
0
416
3659
1.25
2.84
3.6
3.5
0.0
0.0
estimate
0.00
70
678
205
1658
1.31
2.77
1.5
1.5
20.6
20.6
nmol/l
0.01
185
1412
5
6
8.37
2.75
1.0
1.7
—
—
—
0
0
882
8590
1.84
2.74
27.9
19.7
134.6
136.3
g/l
2.86
875
8475
7
14
5.03
2.73
1.0
1.1
—
—
—
0
0
420
3711
1.24
2.72
3.7
3.5
0.0
0.0
estimate
0.80
68
660
97
703
1.43
2.64
2.6
2.5
0.2
0.2
g/l
0.03
90
663
9
25
3.63
2.58
1.0
1.3
—
—
—
0
0
80
562
1.46
2.57
3.8
4.1
1.2
1.2
mmol/l
0.79
70
492
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
50
2.62
2.54
1.0
1.2
—
—
—
0
0
414
3674
1.23
2.51
5.2
4.7
0.0
0.0
estimate
0.50
71
693
28
151
1.88
2.49
2.1
1.5
—
—
—
0
0
103
766
1.39
2.43
4.6
4.4
242.2
252.6
u/l
0.30
96
728
67
461
1.49
2.40
3.8
3.5
4.5
4.6
pmol/l
0.68
62
413
37
221
1.70
2.38
2.0
1.3
11.0
9.5
u/l
0.21
29
178
80
573
1.43
2.34
3.1
2.2
14.3
13.3
nmol/l
0.35
74
512
40
248
1.64
2.25
1.2
1.3
—
—
—
0
0
554
5107
1.22
2.19
3.1
3.1
—
—
—
0
0
12
48
2.52
2.19
1.0
1.1
—
—
—
0
0
8
24
3.35
2.18
1.0
1.1
—
—
—
0
0
8
24
3.35
2.18
1.0
1.2
—
—
—
0
0
6
14
4.31
2.15
1.0
3.5
—
—
—
0
0
71
506
1.44
2.15
2.0
2.9
177.4
162.7
ng/l
0.12
63
458
747
7115
1.28
2.14
22.1
14.2
39.6
40.1
%
1.08
586
5332
37
229
1.64
2.11
2.4
1.8
43.2
38.0
nmol/l
0.40
37
219
104
797
1.34
2.06
2.1
1.8
—
—
—
0
0
8
26
3.09
2.01
1.0
1.1
—
—
—
0
0
40
256
1.59
2.01
1.7
2.3
378.2
301.5
ug/l
0.28
40
239
213
1801
1.24
1.97
2.3
2.1
2.6
3.0
mg/l
1.63
183
1538
75
550
1.40
1.96
3.0
4.0
80.1
82.3
ng/l
0.07
67
492
12
51
2.37
1.95
1.7
1.5
12.0
4.5
u/l
—
7
24
18
92
1.98
1.91
1.0
1.2
—
—
—
0
0
34
212
1.63
1.91
7.4
4.1
3.7
3.9
mmol/l
1.43
34
196
44
293
1.53
1.88
1.4
1.9
—
—
—
0
0
103
800
1.32
1.88
2.1
1.9
—
—
—
0
0
37
237
1.58
1.87
2.2
3.0
—
—
—
0
0
9
34
2.66
1.87
3.4
1.5
—
—
—
0
0
9
34
2.66
1.87
3.4
1.5
—
—
—
0
0
9
34
2.66
1.87
1.0
1.2
—
—
—
0
0
70
513
1.39
1.84
5.7
4.1
5.2
5.1
kpa
0.57
63
483
113
892
1.30
1.84
7.1
6.5
—
—
—
0
0
6
17
3.55
1.84
1.0
1.2
—
—
—
0
0
5
12
4.18
1.82
1.0
1.1
—
—
—
0
0
79
596
1.36
1.76
2.7
2.6
78.5
68.6
ml/min/173m2
0.95
36
234
32
202
1.61
1.73
1.3
1.2
—
—
—
0
0
16
82
1.97
1.70
1.3
1.2
52.7
53.7
u/l
—
9
60
268
2351
1.20
1.70
2.8
2.5
57.4
56.1
u/l
0.22
247
2174
42
285
1.50
1.67
2.1
1.9
3.4
2.3
ug/l
0.21
36
261
42
286
1.49
1.65
1.2
1.2
0.3
1.3
u/ml
—
6
24
25
150
1.69
1.64
3.0
2.2
136.5
130.5
g/l
0.37
16
112
40
270
1.50
1.64
1.4
1.8
—
—
—
0
0
20
113
1.79
1.61
1.4
1.5
0.2
0.4
nmol/l
0.70
15
95
7
26
2.71
1.58
7.9
4.9
—
—
—
0
0
221
1917
1.20
1.57
2.9
2.9
796.4
1085.0
ng/l
1.33
193
1617
41
281
1.48
1.57
1.6
1.4
—
—
—
0
0
345
3116
1.17
1.54
2.2
2.3
75.6
76.1
nmol/l
0.12
309
2818
19
108
1.78
1.51
1.1
1.1
—
—
—
0
0
234
2050
1.19
1.49
1.7
1.7
1.4
1.4
mmol/l
0.26
202
1727
9
37
2.45
1.48
1.0
1.0
—
—
—
0
0
10
45
2.24
1.46
1.7
1.4
—
—
—
0
0
6
22
2.74
1.43
2.2
1.3
2.4
2.8
mmol/l
—
6
22
64
486
1.34
1.40
5.9
4.1
2.0
1.5
mmol/l
0.40
47
359
9
40
2.26
1.40
1.0
2.8
627.1
742.7
u/ml
—
9
40
6
139
0.43
1.40
1.3
1.7
—
—
—
0
0
31
207
1.52
1.37
2.5
1.6
—
—
—
0
0
14
76
1.86
1.30
1.4
1.2
—
—
—
0
0
204
1788
1.18
1.29
1.3
1.3
1.1
1.5
u/ml
0.35
54
495
40
286
1.42
1.27
1.6
2.1
1.1
1.5
g/l
2.07
34
251
19
116
1.65
1.22
1.7
1.3
—
—
—
0
0
45
335
1.36
1.15
6.7
4.7
25.3
24.7
mmol/l
0.71
39
319
8
39
2.06
1.15
1.0
1.1
—
—
—
0
0
5
113
0.44
1.13
1.4
1.5
—
—
—
0
0
157
1372
1.17
1.04
3.1
2.9
0.7
0.7
ug/l
0.74
108
874
9
46
1.97
1.03
1.8
6.3
—
48.5
—
0
11
793
7735
1.19
1.03
4.9
4.8
2.8
2.8
mmol/l
0.47
739
7156
5
22
2.28
1.03
2.0
1.2
—
—
—
0
0
65
520
1.27
1.03
1.3
1.3
302.3
229.0
u/ml
0.22
59
476
32
230
1.41
1.03
1.6
1.5
353.3
300.6
ug/g
0.85
22
143
762
7417
1.17
0.97
4.3
4.4
5.8
5.9
mmol/l
0.77
710
6800
7
36
1.95
0.97
2.1
2.3
—
—
—
0
0
54
428
1.28
0.94
1.1
1.0
—
—
—
0
0
67
546
1.25
0.93
1.4
1.2
86.2
146.8
iu/ml
1.07
26
230
36
271
1.34
0.90
2.5
2.2
127.0
3752.4
u/l
1.71
16
109
8
42
1.91
0.88
1.0
1.0
—
—
—
0
0
13
79
1.65
0.88
1.1
1.3
—
—
—
0
0
24
169
1.43
0.88
2.2
1.7
—
—
—
0
0
10
56
1.79
0.88
1.3
1.4
—
—
—
0
0
15
95
1.59
0.87
1.1
1.9
—
—
—
0
0
34
255
1.35
0.87
1.7
2.6
4.0
3.7
g/l
0.61
28
187
34
255
1.35
0.87
1.7
2.6
—
—
—
0
0
717
6965
1.14
0.87
5.6
5.5
38.5
39.6
mmol/mol
2.82
679
6490
22
153
1.45
0.86
1.1
1.1
0.1
2.6
u/ml
—
9
63
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
21
146
1.45
0.83
2.0
1.5
—
—
—
0
0
14
89
1.58
0.81
4.1
1.6
32.4
32.7
pg
0.07
14
89
13
82
1.59
0.78
3.9
1.9
—
—
—
0
0
63
754
0.82
0.77
1.7
1.7
—
—
—
0
0
16
107
1.50
0.76
1.0
1.1
—
—
—
0
0
14
209
0.66
0.76
1.1
1.4
—
—
—
0
0
13
83
1.57
0.75
1.1
2.0
—
—
—
0
0
9
54
1.67
0.74
1.4
1.7
—
—
—
0
0
5
24
2.09
0.74
1.2
1.6
—
—
—
0
0
8
133
0.60
0.74
1.0
1.1
—
—
—
0
0
27
202
1.35
0.73
2.0
1.9
1.9
5.2
iu/l
—
9
67
15
100
1.51
0.73
1.0
1.9
—
1744.0
—
0
5
19
134
1.43
0.71
5.1
3.4
3.9
4.4
e9/l
0.34
19
134
5
26
1.93
0.70
3.8
2.1
107.8
68.7
ug/l
—
5
26
113
997
1.15
0.70
1.8
1.8
1.5
1.5
%
0.32
101
886
14
93
1.51
0.69
1.4
1.2
—
—
—
0
0
10
157
0.63
0.69
1.8
1.6
—
—
—
0
0
26
341
0.76
0.69
1.2
1.7
3.0
2.9
mg/l
0.02
20
246
25
187
1.35
0.68
2.7
1.8
—
—
—
0
0
214
1971
1.11
0.68
3.9
3.8
0.0
0.0
estimate
1.08
69
672
7
43
1.63
0.67
1.4
1.2
—
—
—
0
0
15
214
0.70
0.67
1.0
1.1
—
7.0
—
0
32
22
292
0.75
0.64
1.0
1.7
—
—
—
0
0
776
7615
1.13
0.63
4.4
4.3
4.7
4.7
mmol/l
0.48
724
7091
13
188
0.69
0.63
1.7
1.7
5518.0
14909.1
e6/l
—
6
143
19
138
1.38
0.63
5.4
3.8
57.8
57.4
%
0.06
19
138
25
191
1.32
0.61
2.6
1.8
—
—
—
0
0
159
1450
1.12
0.61
1.4
1.5
—
—
—
0
0
11
163
0.67
0.60
4.3
3.8
25.2
25.1
mg/l
—
6
99
747
7321
1.11
0.60
4.1
3.9
1.3
1.3
mmol/l
0.52
693
6758
8
54
1.49
0.57
8.0
2.6
—
—
—
0
0
18
133
1.36
0.55
3.1
1.9
—
—
—
0
0
38
312
1.23
0.55
3.8
3.7
25.4
25.1
mmol/l
0.21
38
306
19
142
1.35
0.54
3.7
2.4
17.2
16.4
%
0.29
13
72
6
39
1.54
0.53
2.7
1.7
—
—
—
0
0
6
39
1.54
0.53
2.7
1.7
—
—
—
0
0
202
1881
1.09
0.52
4.0
4.1
21.5
21.1
%
0.16
86
854
28
225
1.25
0.50
1.1
1.2
—
—
—
0
0
19
145
1.32
0.49
1.3
1.5
—
112.5
—
0
27
28
226
1.25
0.48
1.1
1.2
—
—
—
0
0
10
68
1.48
0.47
3.1
1.9
—
—
—
0
0
10
68
1.48
0.47
1.0
1.1
—
—
—
0
0
8
118
0.68
0.46
1.9
2.8
4.4
37.8
u/ml
—
8
112
11
77
1.43
0.45
2.6
3.7
—
—
—
0
0
26
211
1.24
0.44
1.1
1.1
—
—
—
0
0
18
139
1.30
0.44
2.4
1.7
—
—
—
0
0
298
2842
1.07
0.44
3.9
3.6
—
—
—
0
0
769
7579
1.09
0.43
4.4
4.3
1.5
1.5
mmol/l
0.04
717
7022
5
32
1.57
0.42
3.6
1.7
—
—
—
0
0
245
2327
1.07
0.40
4.8
4.7
1.8
2.4
ug/l
2.00
224
2102
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
102
934
1.10
0.39
1.7
2.1
—
—
—
0
0
5
36
1.39
0.38
1.2
3.0
—
63809.0
—
0
7
5
37
1.35
0.37
1.4
1.5
—
—
—
0
0
22
180
1.23
0.36
3.4
2.5
91.9
105.7
ug/min
0.10
12
109
18
144
1.26
0.35
5.2
4.0
138.8
1970.1
u/ml
0.56
18
136
6
44
1.37
0.34
2.7
1.7
—
—
—
0
0
15
118
1.28
0.33
1.0
1.1
—
—
—
0
0
6
47
1.28
0.32
1.2
1.4
—
—
—
0
0
6
47
1.28
0.32
1.0
1.0
189.8
266.6
ng/l
—
6
30
11
83
1.33
0.32
2.5
2.6
105.9
105.0
mmol/l
0.42
11
83
11
83
1.33
0.32
2.5
2.6
4.1
4.1
mmol/l
0.08
11
83
24
202
1.19
0.31
1.3
1.2
—
—
—
0
0
243
2329
1.06
0.31
3.2
3.2
8.3
7.8
mmol/l
0.73
206
1963
7
52
1.35
0.31
1.0
1.3
—
—
—
0
0
172
1631
1.07
0.31
4.0
3.7
1.0
1.0
kg/l
0.17
19
207
132
1241
1.07
0.30
1.7
1.7
1022.5
1188.3
nmol/l
1.45
99
932
7
55
1.27
0.30
3.4
2.5
—
—
—
0
0
79
728
1.09
0.29
4.1
4.5
9.7
26.8
ug/l
0.78
58
607
233
2237
1.06
0.28
4.0
4.0
6.1
8.0
mg/mmol
0.49
143
1412
10
76
1.32
0.28
1.2
1.7
—
—
—
0
0
10
76
1.32
0.28
1.2
1.7
—
—
—
0
0
10
76
1.32
0.28
1.2
1.7
—
—
—
0
0
21
246
0.85
0.26
1.4
1.6
0.1
0.1
iu/ml
—
8
41
5
73
0.68
0.26
1.0
1.4
—
—
—
0
0
9
75
1.20
0.25
1.0
1.3
—
—
—
0
0
29
255
1.14
0.24
1.4
1.9
—
—
—
0
0
6
83
0.72
0.24
1.3
2.4
—
23.4
—
0
21
28
247
1.14
0.23
1.2
1.3
216.5
249.4
miu/ml
0.21
16
115
22
191
1.16
0.22
1.5
1.4
—
—
—
0
0
22
191
1.16
0.22
1.5
1.4
—
—
—
0
0
30
267
1.13
0.22
1.7
1.8
—
—
—
0
0
5
42
1.19
0.21
1.2
1.9
—
—
—
0
0
5
42
1.19
0.21
1.2
1.9
—
—
—
0
0
5
42
1.19
0.21
1.2
1.9
—
—
—
0
0
5
42
1.19
0.21
1.2
1.9
—
—
—
0
0
23
201
1.15
0.21
1.4
1.6
—
—
—
0
0
22
192
1.15
0.21
1.5
1.4
—
—
—
0
0
22
192
1.15
0.21
1.5
1.4
—
—
—
0
0
30
334
0.89
0.20
1.9
1.5
—
—
—
0
0
6
48
1.25
0.20
1.0
1.0
770.7
614.7
ng/l
—
6
31
23
202
1.14
0.20
1.3
1.5
—
—
—
0
0
9
114
0.79
0.20
1.1
1.5
—
—
—
0
0
6
52
1.15
0.19
2.5
1.8
—
—
—
0
0
142
1363
1.05
0.19
1.2
1.3
15.3
35.3
iu/ml
4.30
37
424
13
109
1.20
0.18
2.8
1.7
—
—
—
0
0
7
59
1.19
0.18
1.1
1.2
—
—
—
0
0
7
59
1.19
0.18
1.1
1.2
—
—
—
0
0
7
60
1.17
0.18
1.1
1.2
—
—
—
0
0
7
60
1.17
0.18
1.1
1.2
—
—
—
0
0
7
60
1.17
0.18
1.1
1.2
—
—
—
0
0
155
1495
1.04
0.17
1.5
1.6
447.0
38591302.8
pmol/l
1.92
133
1249
27
243
1.11
0.17
1.6
1.4
0.2
0.2
g/l
0.29
27
231
10
82
1.22
0.17
1.3
1.2
—
—
—
0
0
15
173
0.86
0.17
1.3
1.4
—
—
—
0
0
54
506
1.07
0.16
1.6
1.9
—
—
—
0
0
8
72
1.11
0.16
1.1
1.0
—
—
—
0
0
8
72
1.11
0.16
2.0
2.3
—
—
—
0
0
24
216
1.11
0.15
1.2
1.3
—
—
—
0
0
204
1985
1.04
0.15
2.9
2.7
4486.2
6884.5
umol/l
0.35
176
1733
15
131
1.15
0.14
7.2
3.6
—
2514.4
u/ml
—
0
11
12
138
0.87
0.13
1.3
1.6
—
—
—
0
0
9
106
0.85
0.13
2.2
1.6
—
—
—
0
0
15
133
1.13
0.12
1.1
1.1
—
12.4
—
0
10
43
405
1.06
0.12
1.5
1.8
—
—
—
0
0
12
105
1.14
0.11
1.3
1.4
—
—
—
0
0
12
105
1.14
0.11
1.3
1.4
—
—
—
0
0
12
105
1.14
0.11
1.3
1.4
—
—
—
0
0
12
106
1.13
0.10
1.3
1.4
—
—
—
0
0
12
107
1.12
0.08
1.3
1.4
—
—
—
0
0
12
107
1.12
0.08
1.3
1.4
—
—
—
0
0
7
65
1.08
0.08
1.9
1.6
0.9
1.0
g/l
—
7
65
128
1253
1.03
0.07
1.5
1.4
—
—
—
0
0
23
216
1.07
0.07
1.3
2.2
10.8
11.5
mg/l
0.14
23
198
86
844
1.02
0.04
1.7
1.9
—
—
—
0
0
26
270
0.96
0.03
1.3
1.5
—
—
—
0
0
23
221
1.04
0.03
1.9
1.5
—
—
—
0
0
92
930
0.99
0.02
3.7
4.3
32.5
31.7
%
0.30
63
636
13
123
1.06
0.01
2.0
1.6
—
—
—
0
0
131
1305
1.00
0.00
1.3
1.3
14.6
12.1
u/ml
0.13
57
520
11
109
1.01
0.00
4.4
1.7
—
—
—
0
0
42
415
1.01
0.00
1.5
1.3
—
—
—
0
0
26
255
1.02
0.00
1.7
1.4
1.1
1.2
g/l
0.50
26
240
0
7
0.00
0.00
0.0
1.3
—
0.6
—
0
7
0
6
0.00
0.00
0.0
1.0
—
65.7
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
0.00
1.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
11.3
—
0
9
6
65
0.92
0.00
1.0
1.2
—
70.4
—
0
7
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
17
170
1.00
0.00
1.4
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
10.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
6.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM | 1.412 [1.2, 1.67] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.218 |
During the follow-up period (1.1.1998 — 31.12.2019), 247 out of 2415 females with Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM | 1.509 [1.28, 1.78] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.02 |
During the follow-up period (1.1.1998 — 31.12.2019), 309 out of 2209 males with Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM died.
Mortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.111% | 0.301% |
| 5 | 0.689% | 1.751% |
| 10 | 1.803% | 4.426% |
| 15 | 3.836% | 8.529% |
| 20 | 6.932% | 14.452% |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM – Other congenital malformations of circulatory system
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data